S. GÜR Et Al. , "PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update," CURRENT PHARMACEUTICAL DESIGN , vol.18, no.34, pp.5590-5606, 2012
GÜR, S. Et Al. 2012. PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update. CURRENT PHARMACEUTICAL DESIGN , vol.18, no.34 , 5590-5606.
GÜR, S., Kadowitz, P. J., Serefoglu, E. C., & Hellstrom, W. J. G., (2012). PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update. CURRENT PHARMACEUTICAL DESIGN , vol.18, no.34, 5590-5606.
GÜR, SERAP Et Al. "PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update," CURRENT PHARMACEUTICAL DESIGN , vol.18, no.34, 5590-5606, 2012
GÜR, SERAP Et Al. "PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update." CURRENT PHARMACEUTICAL DESIGN , vol.18, no.34, pp.5590-5606, 2012
GÜR, S. Et Al. (2012) . "PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update." CURRENT PHARMACEUTICAL DESIGN , vol.18, no.34, pp.5590-5606.
@article{article, author={SERAP GÜR Et Al. }, title={PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update}, journal={CURRENT PHARMACEUTICAL DESIGN}, year=2012, pages={5590-5606} }